Citigroup’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Sell |
31,098
-432,142
| -93% | -$2.77M | ﹤0.01% | 3347 |
|
|
2025
Q1 | $1.64M | Sell |
463,240
-146,084
| -24% | -$517K | ﹤0.01% | 2228 |
|
|
2024
Q4 | $2.3M | Buy |
609,324
+34,319
| +6% | +$130K | ﹤0.01% | 2032 |
|
|
2024
Q3 | $1.86M | Sell |
575,005
-88,371
| -13% | -$286K | ﹤0.01% | 2100 |
|
|
2024
Q2 | $1.26M | Sell |
663,376
-251,351
| -27% | -$478K | ﹤0.01% | 2095 |
|
|
2024
Q1 | $2.6M | Buy |
914,727
+527,063
| +136% | +$1.5M | ﹤0.01% | 1651 |
|
|
2023
Q4 | $5.71M | Buy |
387,664
+343,875
| +785% | +$5.06M | ﹤0.01% | 1058 |
|
|
2023
Q3 | $802K | Sell |
43,789
-33,780
| -44% | -$619K | ﹤0.01% | 2064 |
|
|
2023
Q2 | $1.67M | Buy |
77,569
+44,443
| +134% | +$959K | ﹤0.01% | 1833 |
|
|
2023
Q1 | $972K | Buy |
33,126
+23,403
| +241% | +$687K | ﹤0.01% | 2032 |
|
|
2022
Q4 | $359K | Buy |
9,723
+1,002
| +11% | +$37K | ﹤0.01% | 2727 |
|
|
2022
Q3 | $245K | Buy |
8,721
+7,886
| +944% | +$222K | ﹤0.01% | 3003 |
|
|
2022
Q2 | $16K | Sell |
835
-319
| -28% | -$6.11K | ﹤0.01% | 4411 |
|
|
2022
Q1 | $15K | Buy |
+1,154
| New | +$15K | ﹤0.01% | 4542 |
|